FDA Approves TNKase for Acute Ischemic Stroke
The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the ...
Pulmonology Advisor1d
TNKase Approved for Treatment of Acute Ischemic Stroke
The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.
Medical Xpress6d
FDA approves TNKase for acute ischemic stroke
The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults. TNKase is delivered as a ...
U.S. News & World Report6d
FDA Approves TNKase for Acute Ischemic Stroke
The approval is based on a study comparing TNKase to Activase in patients with acute ischemic stroke who presented with a disabling neurological deficit. Results show that TNKase was comparable to ...
Health and Me on MSN5d
FDA Approves TNKase To Treat Ischemic Strokes In Adults
It is delivered as a single five-second intravenous bolus, which is faster than the standard of care Activase or alteplase, ...